MILPITAS, Calif., April 27, 2026 /PRNewswire/ -- Galaxy Therapeutics, a privately held, clinical-stage medical device company focused on treating brain aneurysms, today announced the submission of its final module of its Premarket Approval (PMA) application to the U.S. Food and Drug...
Hence then, the article about galaxy therapeutics submits final module of pma to u s fda for seal device in wide neck bifurcation aneurysms was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Galaxy Therapeutics Submits Final Module of PMA to U.S. FDA for SEAL™ Device in Wide-Neck Bifurcation Aneurysms )
Also on site :
- Marshals Episode 9 Ends With Chilling Warning From Kayce's Nemesis: 'Like The Duttons, My Legacy Is Growing'
- ‘The Night Manager’ Team Discusses How One-Off Limited Series Became Trilogy, Vows That Season 3 “Won’t Take As Long As The Last One” – Contenders TV
- Oil prices rise higher amid stalled US-Iran peace talks